Inhibition of phosphoinositide 3-kinase is associated with reduced angiogenesis and an altered expression of angiogenic markers in endothelioma cells

Biomedicine and Pharmacotherapy

Volumn 68, Issue 5, 2014, Pages 611-617

  Mabeta, P ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

002; Akt; Angiogenesis; Endothelioma; LY294; PI3k

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CRYSTAL VIOLET; EOTAXIN; FAS LIGAND; FIBROBLAST GROWTH FACTOR 2; PROTEIN KINASE B; THROMBOCYTE FACTOR 4; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANGIOGENIC FACTOR; CASPASE; CHROMONE DERIVATIVE; MORPHOLINE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR; TUMOR MARKER;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; AORTA RING ASSAY; ARTICLE; ASSAY; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; CORRELATIONAL STUDY; CRYSTAL VIOLET ASSAY; DRUG EFFECT; ENDOTHELIOMA; ENDOTHELIOMA CELL; ENDOTHELIUM CELL; MALE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; TUMOR CELL CULTURE; TUMOR GROWTH; VASCULAR TUMOR; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTA; CELL MOTION; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; DRUG EFFECTS; ENZYMOLOGY; HEMANGIOENDOTHELIOMA; IN VITRO STUDY; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; AORTA; BIOMARKERS, TUMOR; CASPASES; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CHROMONES; HEMANGIOENDOTHELIOMA; IN VITRO TECHNIQUES; MALE; MICE; MORPHOLINES; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; RATS, SPRAGUE-DAWLEY;

EID: 84905114229     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.03.017     Document Type: Article

References (29)

1. Du W., Gerald D., Carole A., Perruzzi C.A., Rodriguez-Waitkus P., Enayati L., et al. Vascular tumors have increased p70 S6-Kinase activation and are inhibited by topical Rapamycin. Lab Invest 2013, 93:1115-1127.
2. Jiang B.H., Zheng J.Z., Aoki M., Vogt P.K. Phosphotidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. PNAS 2000, 97:1749-1753.
3. Mabeta P., Pepper M.S. Inhibition of hemangioma development in a syngeneic mouse model correlates with Bcl-2 suppression and the inhibition of Akt kinase activity. Angiogenesis 2012, 15:131-139.
4. Vivanco I., Sawyers C.S. The Phosphotidylinositol 3-Kinase-Akt pathway in human cancer. Nat Rev Cancer 2002, 2:489-501.
5. Gharbi S.I., Zvelebil M.J., Shuttleworth S.J., Hancox T., Saghir N. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J 2007, 404:15-21.
6. Dituri F., Mazzocca A., Giannelli G., Antonaci S. PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors. Clin Dev Immunol 2011, 2011:947858-947958.
7. Gerard N., Caillaud M., Martoriati A., Goudet G., Lalmanach A. The Interleukin-I system and female reproduction. J Endocrinol 2004, 180:203-212.
8. Moon D.-O., Park S.-Y., Choi Y.H., Kim N.D., Lee C., Kim G.-Y. Melittin induces Bcl-2 and Caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells. Toxicon 2008, 51:112-120.
9. Porter A.G., Janicke R.U. Emerging roles of Caspase-3 in apoptosis. Cell Death Differ 1999, 6:99-104.
10. Okumura N., Yoshida H., Kitagishi Y., Murakami M., Nishimura Y., Matsuda S. PI3K/AKT/PTEN signaling as a molecular target in leukemia angiogenesis. Adv Hematol 2012, 1:1-6.
11. Montesano R., Pepper M.S., Möhle-Steinlein U., Risau W., Wagner E.F., Orci L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the Middle T Oncogene. Cell 1990, 62:435-445.
12. Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., Waterfield M.D. Cellular function of phosphoinositide 3-kinases: Implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2001, 17:615-675.
13. Graupera M., Potente M. Regulation of angiogenesis by PI3k signaling networks. Exp Cell Res 2013, 319:1348-1355.
14. Jiang B.H., Liu L.Z. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 2008, 102:150-158.
15. Shiojima I., Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 2002, 90:1243-1250.
16. Mabeta P., Pepper M.S. A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents. Angiogenesis 2009, 12:18-90.
17. Kaplan H.J., Leibole M.A., Tezel T., Ferguson T.A. Fas Ligand (CD95 Ligand) controls angiogenesis beneath the retina. Nat Med 1999, 5:292-297.
18. Voss M., Lettau M., Paulsen M., Janssen O. Posttranslational regulation of Fas ligand function. Cell Commun Signal 2008, 6:11-23.
19. Bikfalvi A. Platelet Factor 4: an inhibitor of angiogenesis. Semin Thromb Hemost 2004, 30:379-385.
20. Bikfalvi A. Recent developments in the inhibition of angiogenesis: examples from studies on Platelet Factor-4 and the VEGF/VEGFR system. Biochem Pharmacol 2004, 68:1017-1021.
21. Aidoudi S.B.A. Interaction of PF4 (CXCL4) with the vasculature: role in atherosclerosis and angiogenesis. Thromb Hemost 2010, 104:941-948.
22. Cross M.J.C.L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001, 22:201-207.
23. Levina V., Nolen B.M., Marrangoni A.M., et al. Role of Eotaxin-1 signaling in ovarian cancer. Clin Cancer Res 2009, 15:2647-2656.
24. Salcedo R., Young H.A., Ponce M.L., Ward J.M., Kleinman H.K., Murphy W.J., et al. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol 2001, 166:7571-7578.
25. Houseknecht K.L., Baile C.A., Matteri R.L., Spurlock M.E. The biology of leptin: a review. J Anim Sci 1998, 76:1405-1420.
26. Margetic S., Gazzola C., Pegg G.G., Hill R.A. Leptin: a review of its peripheral actions and interactions. Int J Obesity 2002, 26:1407-1410.
27. Gonzalez-Perez R.R., Lanier V., Newman G. Leptin's pro-angiogenic signature in breast cancer. Cancers 2013, 5:1140-1150.
28. Vona-Davis L., Rose D.P. Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev 2009, 20:193-201.
29. Kelesidis T., Kelesidis I., Chou S., Mantzoros C.S. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Int Med 2010, 152:93-100.